Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 324

1.

Big Data and Artificial Intelligence:Will they change our practice?

Kedra J, Gossec L.

Joint Bone Spine. 2019 Sep 11. pii: S1297-319X(19)30120-4. doi: 10.1016/j.jbspin.2019.09.001. [Epub ahead of print] No abstract available.

PMID:
31520738
2.

Criteria for inclusion in programs of functional restoration for chronic low back pain: Pragmatic Study.

Assadourian M, Bailly F, Letellier P, Potel A, Duplan B, Beaudreuil J, Dupeyron A, Foltz V, Ibrahim-Nasser N, Griffoul I, Ascione S, Morardet L, Le Ralle M, Fautrel B, Gossec L.

Ann Phys Rehabil Med. 2019 Aug 14. pii: S1877-0657(19)30112-5. doi: 10.1016/j.rehab.2019.06.019. [Epub ahead of print]

PMID:
31421275
3.

Current status of use of big data and artificial intelligence in RMDs: a systematic literature review informing EULAR recommendations.

Kedra J, Radstake T, Pandit A, Baraliakos X, Berenbaum F, Finckh A, Fautrel B, Stamm TA, Gomez-Cabrero D, Pristipino C, Choquet R, Servy H, Stones S, Burmester G, Gossec L.

RMD Open. 2019 Jul 18;5(2):e001004. doi: 10.1136/rmdopen-2019-001004. eCollection 2019.

4.

Self-reported competencies and educational needs of rheumatology nurses: Results of a national survey.

Beauvais C, Gossec L, Mulliez A, Fayet F, Poilverd RM, Pouplin S, Perrot S, L'amour C, Carton L, Aubert MP, Miconnet S, Grange L, Flipon-Cousin E, Mézieres M, Dougados M, Jaccaz-Vallée N, Savel C.

Joint Bone Spine. 2019 Jul 4. pii: S1297-319X(19)30102-2. doi: 10.1016/j.jbspin.2019.06.010. [Epub ahead of print] No abstract available.

PMID:
31279742
5.

Screening for and management of comorbidities after a nurse-led program: results of a 3-year longitudinal study in 769 established rheumatoid arthritis patients.

Gossec L, Soubrier M, Foissac F, Molto A, Richette P, Beauvais C, Ruyssen-Witrand A, Perdriger A, Chary-Valckenaere I, Mouterde G, Dernis E, Euller-Ziegler L, Flipo RM, Gilson M, Guis S, Mariette X, Pouplin S, Marhadour T, Schaeverbeke T, Sordet C, Fayet F, Dougados M.

RMD Open. 2019 Jun 14;5(2):e000914. doi: 10.1136/rmdopen-2019-000914. eCollection 2019.

6.

Evaluation of the performances of 'typical' imaging abnormalities of axial spondyloarthritis: results of the cross-sectional ILOS-DESIR study.

Molto A, Gossec L, Lefèvre-Colau MM, Foltz V, Beaufort R, Laredo JD, Richette P, Dieude P, Goupille P, Feydy A, Dougados M.

RMD Open. 2019 May 28;5(1):e000918. doi: 10.1136/rmdopen-2019-000918. eCollection 2019.

7.

Spinal-pelvic orientation: potential effect on the diagnosis of spondyloarthritis.

Carvajal Alegria G, Deloire L, Herbette M, Garrigues F, Gossec L, Simon A, Feydy A, Reijnierse M, van der Heijde D, Loeuille D, Claudepierre P, Marhadour T, Saraux A.

Rheumatology (Oxford). 2019 Jun 24. pii: kez240. doi: 10.1093/rheumatology/kez240. [Epub ahead of print]

PMID:
31236597
8.

EULAR points to consider for the use of big data in rheumatic and musculoskeletal diseases.

Gossec L, Kedra J, Servy H, Pandit A, Stones S, Berenbaum F, Finckh A, Baraliakos X, Stamm TA, Gomez-Cabrero D, Pristipino C, Choquet R, Burmester GR, Radstake TRDJ.

Ann Rheum Dis. 2019 Jun 22. pii: annrheumdis-2019-215694. doi: 10.1136/annrheumdis-2019-215694. [Epub ahead of print]

PMID:
31229952
9.

Essential knowledge for patients with rheumatoid arthritis or spondyloarthritis: Results of a multicentric survey in France among health professionals and patients.

Beauvais C, Rodère M, Pereira B, Legoupil N, Piperno M, Pallot Prades B, Castaing P, Wendling D, Grange L, Costantino F, Carton L, Soubrier M, Coquerelle P, Pham T, Poivret D, Cohen JD, Tavares I, Nataf H, Pouplin S, Sordet C, Gossec L.

Joint Bone Spine. 2019 Jun 19. pii: S1297-319X(19)30098-3. doi: 10.1016/j.jbspin.2019.06.006. [Epub ahead of print]

PMID:
31228620
10.

Gender equity in clinical practice, research and training: Where do we stand in rheumatology?

Andreoli L, Ovseiko PV, Hassan N, Kiltz U, van Mens L, Gossec L, Coates LC.

Joint Bone Spine. 2019 Jun 17. pii: S1297-319X(19)30095-8. doi: 10.1016/j.jbspin.2019.05.005. [Epub ahead of print] No abstract available.

PMID:
31220622
11.

Knowledge of and expectations about functional restoration programs for chronic low back pain: A mirror survey of 150 patients and 80 physicians in 2017.

Letellier P, Bailly F, Assadourian M, Potel A, Foltz V, Ascione S, Morardet L, Le Ralle M, Fautrel B, Dupeyron A, Ibrahim-Nasser N, Griffoul-Espitalier I, Duplan B, Beaudreuil J, Gossec L.

Joint Bone Spine. 2019 Jun 16. pii: S1297-319X(19)30093-4. doi: 10.1016/j.jbspin.2019.06.002. [Epub ahead of print] No abstract available.

PMID:
31216489
12.

Psychometric properties and cross-language equivalence of the revised Bristol Rheumatoid Arthritis Fatigue and the Rheumatoid Arthritis Impact of Disease scales in rheumatoid arthritis.

Oude Voshaar MAH, Bode C, Hewlett S, Kirwan J, Gossec L, van de Laar MAFJ.

Qual Life Res. 2019 Sep;28(9):2543-2552. doi: 10.1007/s11136-019-02188-8. Epub 2019 Apr 26.

13.

Is a positive family history of spondyloarthritis relevant for diagnosing axial spondyloarthritis once HLA-B27 status is known?

van Lunteren M, van der Heijde D, Sepriano A, Berg IJ, Dougados M, Gossec L, Jacobsson L, Ramonda R, Rudwaleit M, Sieper J, Landewé R, van Gaalen FA.

Rheumatology (Oxford). 2019 Sep 1;58(9):1649-1654. doi: 10.1093/rheumatology/kez095.

14.

Is self-assessment by patients of disease activity acceptable over the long term in rheumatoid arthritis? A 3-year follow-up of 771 patients.

Gossec L, Fayet F, Soubrier M, Foissac F, Molto A, Richette P, Beauvais C, Ruyssen-Witrand A, Perdriger A, Chary-Valckenaere I, Mouterde G, Dernis E, Euller-Ziegler L, Flipo RM, Gilson M, Balandraud N, Mariette X, Pouplin S, Marhadour T, Schaeverbeke T, Sordet C, Dougados M.

Rheumatology (Oxford). 2019 Aug 1;58(8):1498-1499. doi: 10.1093/rheumatology/kez094. No abstract available.

PMID:
30915463
15.

Effects of Sarilumab on Rheumatoid Arthritis as Reported by Patients Using the Rheumatoid Arthritis Impact of Disease Scale.

Gossec L, Strand V, Proudfoot C, Chen CI, Guillonneau S, Kimura T, van Hoogstraten H, Mangan E, Reaney M.

J Rheumatol. 2019 Mar 15. pii: jrheum.180904. doi: 10.3899/jrheum.180904. [Epub ahead of print]

16.

Evaluation of the Implementation of Guidelines on the Treatment of Osteoporosis in Patients with Rheumatoid Arthritis.

Malochet-Guinamand S, Lambert C, Gossec L, Soubrier M, Dougados M.

J Rheumatol. 2019 Mar 15. pii: jrheum.180889. doi: 10.3899/jrheum.180889. [Epub ahead of print]

PMID:
30877214
17.

The European Map of Axial Spondyloarthritis: Capturing the Patient Perspective-an Analysis of 2846 Patients Across 13 Countries.

Garrido-Cumbrera M, Poddubnyy D, Gossec L, Gálvez-Ruiz D, Bundy C, Mahapatra R, Makri S, Christen L, Delgado-Domínguez CJ, Sanz-Gómez S, Plazuelo-Ramos P, Navarro-Compán V; EMAS Working Group.

Curr Rheumatol Rep. 2019 Mar 12;21(5):19. doi: 10.1007/s11926-019-0819-8. Review.

18.

Similar alteration for mental and physical aspects in health-related quality of life over 5 to 8 years in 1347 patients with early arthritis and early inflammatory back pain.

Puyraimond-Zemmour D, Granger B, Molto A, Gaujoux-Viala C, Guillemin F, Ruyssen-Witrand A, Dougados M, Fautrel B, Gossec L.

Arthritis Res Ther. 2019 Feb 19;21(1):63. doi: 10.1186/s13075-019-1841-y.

19.

OMERACT Filter 2.1: Elaboration of the Conceptual Framework for Outcome Measurement in Health Intervention Studies.

Boers M, Beaton DE, Shea BJ, Maxwell LJ, Bartlett SJ, Bingham CO 3rd, Conaghan PG, D'Agostino MA, de Wit MP, Gossec L, March L, Simon LS, Singh JA, Strand V, Wells GA, Tugwell P.

J Rheumatol. 2019 Aug;46(8):1021-1027. doi: 10.3899/jrheum.181096. Epub 2019 Feb 15.

PMID:
30770515
20.

Core Domain Set Selection According to OMERACT Filter 2.1: The OMERACT Methodology.

Maxwell LJ, Beaton DE, Shea BJ, Wells GA, Boers M, Grosskleg S, Bingham CO 3rd, Conaghan PG, D'Agostino MA, de Wit M, Gossec L, March L, Simon LS, Singh JA, Strand V, Tugwell P.

J Rheumatol. 2019 Aug;46(8):1014-1020. doi: 10.3899/jrheum.181097. Epub 2019 Feb 15.

PMID:
30770502
21.

Assessment of the adherence to disease-modifying drugs in patients with chronic inflammatory rheumatic diseases: Results of a survey of 1594 patients.

López-Medina C, Moltó A, Gérald F, Dubremetz M, Grange L, Thibaud G, Charles B, Lafarge D, Beauvais C, Gossec L, Dougados M.

Joint Bone Spine. 2019 Feb 7. pii: S1297-319X(19)30020-X. doi: 10.1016/j.jbspin.2019.01.023. [Epub ahead of print]

PMID:
30738192
22.

Workforce requirements in rheumatology: a systematic literature review informing the development of a workforce prediction risk of bias tool and the EULAR points to consider.

Unger J, Putrik P, Buttgereit F, Aletaha D, Bianchi G, Bijlsma JWJ, Boonen A, Cikes N, Dias JM, Falzon L, Finckh A, Gossec L, Kvien TK, Matteson EL, Sivera F, Stamm TA, Szekanecz Z, Wiek D, Zink A, Dejaco C, Ramiro S.

RMD Open. 2018 Dec 5;4(2):e000756. doi: 10.1136/rmdopen-2018-000756. eCollection 2018.

23.

EULAR 'points to consider' for the conduction of workforce requirement studies in rheumatology.

Dejaco C, Putrik P, Unger J, Aletaha D, Bianchi G, Bijlsma JW, Boonen A, Cikes N, Finckh A, Gossec L, Kvien TK, Madruga Dias J, Matteson EL, Sivera F, Stamm TA, Szekanecz Z, Wiek D, Zink A, Ramiro S, Buttgereit F.

RMD Open. 2018 Dec 5;4(2):e000780. doi: 10.1136/rmdopen-2018-000780. eCollection 2018.

24.

Instrument Selection Using the OMERACT Filter 2.1: The OMERACT Methodology.

Beaton DE, Maxwell LJ, Shea BJ, Wells GA, Boers M, Grosskleg S, Bingham CO 3rd, Conaghan PG, D'Agostino MA, de Wit MP, Gossec L, March LM, Simon LS, Singh JA, Strand V, Tugwell P.

J Rheumatol. 2019 Aug;46(8):1028-1035. doi: 10.3899/jrheum.181218. Epub 2019 Feb 1.

PMID:
30709952
25.

The effects of cultural background on patient-perceived impact of psoriatic arthritis - a qualitative study conducted in Brazil and France.

Palominos PE, Gossec L, Kreis S, Hinckel CL, da Silva Chakr RM, Moro ALD, Campbell W, de Wit M, Goel N, Kohem CL, Xavier RM.

Adv Rheumatol. 2018 Oct 22;58(1):33. doi: 10.1186/s42358-018-0036-6.

PMID:
30657095
26.

Fears and beliefs of people living with rheumatoid arthritis: a systematic literature review.

Palominos PE, Gasparin AA, de Andrade NPB, Xavier RM, da Silva Chakr RM, Igansi F, Gossec L.

Adv Rheumatol. 2018 May 24;58(1):1. doi: 10.1186/s42358-018-0001-4. Review.

PMID:
30657055
27.

Acute anterior uveitis in spondyloarthritis: a monocentric study of 301 patients.

Frantz C, Portier A, Etcheto A, Monnet D, Brezin A, Roure F, Elhai M, Burki V, Fabreguet I, Koumakis E, Payet J, Gossec L, Dougados M, Molto A.

Clin Exp Rheumatol. 2019 Jan-Feb;37(1):26-31. Epub 2018 Dec 19.

28.

PsAID12 Provisionally Endorsed at OMERACT 2018 as Core Outcome Measure to Assess Psoriatic Arthritis-specific Health-related Quality of Life in Clinical Trials.

Orbai AM, Holland R, Leung YY, Tillett W, Goel N, Christensen R, McHugh N, Gossec L, de Wit M, Højgaard P, Coates LC, Mease PJ, Birt J, Fallon L, FitzGerald O, Ogdie A, Shea B, Strand V, Duffin KC, Tugwell P, Beaton D, Gladman DD.

J Rheumatol. 2019 Aug;46(8):990-995. doi: 10.3899/jrheum.181077. Epub 2018 Dec 15.

PMID:
30554154
29.

Secukinumab provides sustained PASDAS-defined remission in psoriatic arthritis and improves health-related quality of life in patients achieving remission: 2-year results from the phase III FUTURE 2 study.

Coates LC, Gladman DD, Nash P, FitzGerald O, Kavanaugh A, Kvien TK, Gossec L, Strand V, Rasouliyan L, Pricop L, Ding K, Jugl SM, Gaillez C; FUTURE 2 study group.

Arthritis Res Ther. 2018 Dec 7;20(1):272. doi: 10.1186/s13075-018-1773-y.

30.

Comparing patient-perceived and physician-perceived remission and low disease activity in psoriatic arthritis: an analysis of 410 patients from 14 countries.

Gorlier C, Orbai AM, Puyraimond-Zemmour D, Coates LC, Kiltz U, Leung YY, Palominos P, Cañete JD, Scrivo R, Balanescu A, Dernis E, Tälli S, Ruyssen-Witrand A, Soubrier M, Aydin SZ, Eder L, Gaydukova I, Lubrano E, Kalyoncu U, Richette P, Husni ME, de Wit M, Smolen JS, Gossec L.

Ann Rheum Dis. 2019 Feb;78(2):201-208. doi: 10.1136/annrheumdis-2018-214140. Epub 2018 Nov 15.

31.

Evaluation of the performance of extreme patient-reported outcomes as surrogate markers for fibromyalgia in axial spondyloarthritis.

Santos-Faria D, Dougados M, Gossec L, Perrot S, Moltó A.

Rheumatol Int. 2019 Jan;39(1):141-146. doi: 10.1007/s00296-018-4200-4. Epub 2018 Nov 9.

PMID:
30413924
32.

The International Consortium for Health Outcome Measurement (ICHOM)Set of Outcomes that Matter to People Living with Inflammatory Arthritis Consensus from an international Working Group.

Oude Voshaar MAH, Das Gupta Z, Bijlsma JWJ, Boonen A, Chau J, Courvoisier DS, Curtis JR, Ellis B, Ernestam S, Gossec L, Hale C, Hornjeff J, Leung KYY, Lidar M, Mease P, Michaud K, Mody GM, Ndosi M, Opava CH, Pinheiro GRC, Salt M, Soriano ER, Taylor WJ, Voshaar MJH, Weel AEAM, de Wit M, Wulffraat N, van de Laar MAFJ, Vonkeman HE.

Arthritis Care Res (Hoboken). 2018 Oct 24. doi: 10.1002/acr.23799. [Epub ahead of print]

PMID:
30358135
33.

Towards standardized patient reported physical function outcome reporting: linking ten commonly used questionnaires to a common metric.

Oude Voshaar MAH, Vonkeman HE, Courvoisier D, Finckh A, Gossec L, Leung YY, Michaud K, Pinheiro G, Soriano E, Wulfraat N, Zink A, van de Laar MAFJ.

Qual Life Res. 2019 Jan;28(1):187-197. doi: 10.1007/s11136-018-2007-0. Epub 2018 Oct 13.

34.

Update of French society for rheumatology recommendations for managing rheumatoid arthritis.

Daien C, Hua C, Gaujoux-Viala C, Cantagrel A, Dubremetz M, Dougados M, Fautrel B, Mariette X, Nayral N, Richez C, Saraux A, Thibaud G, Wendling D, Gossec L, Combe B.

Joint Bone Spine. 2019 Mar;86(2):135-150. doi: 10.1016/j.jbspin.2018.10.002. Epub 2018 Oct 10.

PMID:
30315988
35.

Recommendations for the assessment and optimization of adherence to disease-modifying drugs in chronic inflammatory rheumatic diseases: A process based on literature reviews and expert consensus.

Gossec L, Molto A, Romand X, Puyraimond-Zemmour D, Lavielle M, Beauvais C, Senbel E, Flipo RM, Pouplin S, Richez C, Saraux A, Mézières M, Gutermann L, Gaudin P, Wendling D, Dougados M.

Joint Bone Spine. 2019 Jan;86(1):13-19. doi: 10.1016/j.jbspin.2018.08.006. Epub 2018 Sep 19.

36.

Detection of flares by decrease in physical activity, collected using wearable activity trackers, in rheumatoid arthritis or axial spondyloarthritis: an application of Machine-Learning analyses in rheumatology.

Gossec L, Guyard F, Leroy D, Lafargue T, Seiler M, Jacquemin C, Molto A, Sellam J, Foltz V, Gandjbakhch F, Hudry C, Mitrovic S, Fautrel B, Servy H.

Arthritis Care Res (Hoboken). 2018 Sep 22. doi: 10.1002/acr.23768. [Epub ahead of print]

PMID:
30242992
37.

Use of Wearable Activity Trackers to Improve Physical Activity Behavior in Patients With Rheumatic and Musculoskeletal Diseases: A Systematic Review and Meta-Analysis.

Davergne T, Pallot A, Dechartres A, Fautrel B, Gossec L.

Arthritis Care Res (Hoboken). 2019 Jun;71(6):758-767. doi: 10.1002/acr.23752. Epub 2019 Apr 23.

PMID:
30221489
38.

Correction to: Development and application of a questionnaire to assess patient beliefs in rheumatoid arthritis and axial spondyloarthritis.

Gossec L, Berenbaum F, Chauvin P, Hudry C, Cukierman G, de Chalus T, Dreuillet C, Saulot V, Tong S, Russo-Marie F, Joubert JM, Saraux A.

Clin Rheumatol. 2018 Oct;37(10):2659. doi: 10.1007/s10067-018-4241-9.

39.

Dual target strategy: a proposal to mitigate the risk of overtreatment and enhance patient satisfaction in rheumatoid arthritis.

Ferreira RJO, Ndosi M, de Wit M, Santos EJF, Duarte C, Jacobs JWG, Machado PM, van der Heijde D, Gossec L, da Silva JAP.

Ann Rheum Dis. 2019 Oct;78(10):e109. doi: 10.1136/annrheumdis-2018-214199. Epub 2018 Aug 20. No abstract available.

PMID:
30127056
40.

Methods to improve medication adherence in patients with chronic inflammatory rheumatic diseases: a systematic literature review.

Lavielle M, Puyraimond-Zemmour D, Romand X, Gossec L, Senbel E, Pouplin S, Beauvais C, Gutermann L, Mezieres M, Dougados M, Molto A.

RMD Open. 2018 Jul 27;4(2):e000684. doi: 10.1136/rmdopen-2018-000684. eCollection 2018.

41.

The Portuguese Rheumatoid Arthritis Impact of Disease (RAID) score and its measurement equivalence in three countries: validation study using Rasch Models.

Ferreira RJO, Gossec L, Duarte C, Nicklin JK, Hewlett S, da Silva JAP, Ndosi M.

Qual Life Res. 2018 Nov;27(11):2909-2921. doi: 10.1007/s11136-018-1959-4. Epub 2018 Aug 1.

42.

Reply to the comment of Alkan Melikoglu 'Joint manifestations can provide diagnostic clues in Morquio syndrome, a case report'.

Mitrovic S, Gouze H, Schaeverbeke T, Gossec L, Fautrel B.

Joint Bone Spine. 2019 Jan;86(1):123-124. doi: 10.1016/j.jbspin.2018.06.016. Epub 2018 Jul 29. No abstract available.

PMID:
30064008
43.

Frequency of tumour necrosis factor alpha receptor superfamily 1A multiple sclerosis-associated variants in patients with rheumatoid arthritis with anti-tumour necrosis factor therapy-related demyelinating complications.

Bitoun S, Miceli-Richard C, Verstuyft C, Juge PA, Dieudé P, Berthelot JM, Richez C, Cauquil C, Sordet C, Melac-Ducamp S, Gossec L, Bouvard B, Dernis E, Houvenagel E, Boutry-Bacle MA, Mariette X, Seror R.

Ann Rheum Dis. 2018 Dec;77(12):1835-1836. doi: 10.1136/annrheumdis-2018-213183. Epub 2018 Jul 20. No abstract available.

PMID:
30030263
44.

Impact of comorbidities on fatigue in rheumatoid arthritis patients: Results from a nurse-led program for comorbidities management (COMEDRA).

Tournadre A, Pereira B, Gossec L, Soubrier M, Dougados M.

Joint Bone Spine. 2019 Jan;86(1):55-60. doi: 10.1016/j.jbspin.2018.06.010. Epub 2018 Jul 17.

PMID:
30025953
45.

Factors associated with the orthopaedic surgeon's decision to recommend total joint replacement in hip and knee osteoarthritis: an international cross-sectional study of 1905 patients.

Huynh C, Puyraimond-Zemmour D, Maillefert JF, Conaghan PG, Davis AM, Gunther KP, Hawker G, Hochberg MC, Kloppenburg M, Lim K, Lohmander LS, Mahomed NN, March L, Pavelka K, Punzi L, Roos EM, Sanchez-Riera L, Singh JA, Suarez-Almazor ME, Dougados M, Gossec L.

Osteoarthritis Cartilage. 2018 Oct;26(10):1311-1318. doi: 10.1016/j.joca.2018.06.013. Epub 2018 Jul 11.

46.

Prevalence of degenerative changes and overlap with spondyloarthritis-associated lesions in the spine of patients from the DESIR cohort.

de Bruin F, Treyvaud MO, Feydy A, de Hooge M, Pialat JB, Dougados M, Gossec L, Bloem JL, van der Heijde D, Reijnierse M.

RMD Open. 2018 Jun 6;4(1):e000657. doi: 10.1136/rmdopen-2018-000657. eCollection 2018.

47.

Development and application of a questionnaire to assess patient beliefs in rheumatoid arthritis and axial spondyloarthritis.

Gossec L, Berenbaum F, Chauvin P, Hudry C, Cukierman G, de Chalus T, Dreuillet C, Saulot V, Tong S, Russo-Marie F, Joubert JM, Saraux A.

Clin Rheumatol. 2018 Oct;37(10):2649-2657. doi: 10.1007/s10067-018-4172-5. Epub 2018 Jun 12. Erratum in: Clin Rheumatol. 2018 Aug 24;:.

48.

Patient-reported outcomes from a randomized phase III trial of sarilumab monotherapy versus adalimumab monotherapy in patients with rheumatoid arthritis.

Strand V, Gossec L, Proudfoot CWJ, Chen CI, Reaney M, Guillonneau S, Kimura T, van Adelsberg J, Lin Y, Mangan EK, van Hoogstraten H, Burmester GR.

Arthritis Res Ther. 2018 Jun 19;20(1):129. doi: 10.1186/s13075-018-1614-z.

49.

Ability of disease-modifying antirheumatic drugs to prevent or delay rheumatoid arthritis onset: a systematic literature review and meta-analysis.

Hilliquin S, Hugues B, Mitrovic S, Gossec L, Fautrel B.

Ann Rheum Dis. 2018 Aug;77(8):1099-1106. doi: 10.1136/annrheumdis-2017-212612. Epub 2018 Jun 8.

PMID:
29884751
50.

Quality of life in psoriatic arthritis.

Gudu T, Gossec L.

Expert Rev Clin Immunol. 2018 May;14(5):405-417. doi: 10.1080/1744666X.2018.1468252. Epub 2018 Apr 30. Review.

PMID:
29681202

Supplemental Content

Loading ...
Support Center